Managing Principal Joshua White to join GCR Live panel on efficiencies in Merger Control. Event:GCR Live: Global Merger Control Dates: October 22-23, 2026 Host: Global Competition Review Location: Brussels, Belgium Analysis Group Managing Principal Joshua White will speak on a panel exploring efficiencies in UK, EU, and US merger control during the GCR Live: Global Merger Control 2026 conference. Mr. White will join private practitioners and economic experts to debate the adequacy of efficiencies assessments in the respective guidelines and possible improvements. The discussion will explore whether agencies are willing to accept remedies tailored to protect efficiencies and how interdisciplinary insights from management, financial advisers, and management consultants could be better leveraged in assessing efficiencies. The panel will also feature Giorgio Motta (Skadden), Alexander Fritzsche (Gleiss Lutz), Mette Alfter (Frontier Economics), and Raphael De Coninck (Charles River Associates).

Mortgage rates likely to hold stead steady following July Fed meeting, but uncertainty looms as fall approaches. Published on July 29th, 2026 by Chen Zhao Takeaway: Mortgage rates will largely stay the same for now as the Fed opts against hiking and says little about future plans. There was a historically high level of uncertainty going into this meeting, but ultimately, the Fed decided against hiking today because financial markets did their work for them. * The actions coming out of Fed meetings are usually foregone conclusions based on economic data and commentary from Fed officials in the weeks leading up to the meeting. Chairman Warsh has made it his mission to shroud the meetings in mystery. As such, markets placed a roughly one third probability on a 25 bps hike coming out of today's meeting, the highest level of uncertainty in decades. * The committee ultimately opted to hold though three members dissented in favor of a hike. * In explaining today's decision despite his repeated assurance that the Fed is committed to bringing inflation down, Chair Warsh pointed to rates in the time between the last meeting and today. In other words, because financial markets had priced in higher rates anticipating some possibility of a hike, he views that as enough to restrain economic activity and help bring inflation down. Markets had previously been of the view that if the Fed didn't hike today, they would in the September meeting, but now they are less sure. Ultimately, despite Chair Warsh's protests against data dependence, the September decision is likely going to be dependent on the inflation and jobs data between now and then. * Markets have repriced the odds of a hike at the mid-September meeting down from nearly 100% closer to 50/50. * Warsh is clearly determined not to tip his hand for September, but the other 11 voting members of the FOMC will likely offer some commentary. Regardless, if the inflation and jobs data over the next six weeks clearly point in favor of hiking or holding, it would be difficult for the Fed to truly offer a surprising outcome. Chen Zhao is the head of economics research, where she produces research on the housing market for public and internal audiences. Previously, she was an executive director leading housing finance and financial markets research at the JPMorgan Chase Institute. Prior to joining JPMCI, Chen was an economics consultant at Analysis Group, Inc., where she worked on financial litigation cases and led teams conducting health economics and outcomes research on behalf of pharmaceutical companies. While in graduate school, Chen was with the Center for Economic Studies and the Social Economic and Housing Statistics Division at the US Census Bureau, where she conducted applied microeconomics research using large scale restricted-access linked survey-administrative data. She started her career at the White House Council of Economic Advisers, where she focused on labor and health economics.

Vice President Erica VanSant to join panel on MFN Drug Pricing at the 13th Annual Summit for Women Leaders in Life Sciences Law. Event:Women Leaders in Life Sciences Law Date: July 30, 2026 Host: American Conference Institute (ACI) Location: Boston, MA Times: 8:00-8:45 a.m. (PT) / 11:00-11:45 a.m. (ET) Analysis Group Vice President Erica VanSant will join a panel on Most Favored Nation (MFN) drug pricing at the 13th Annual Summit for Women Leaders in Life Sciences Law. The session, MFN Drug Pricing and the Future of Global Pharmaceutical Markets: Understanding the Implications for Pricing, Access, and Innovation, will examine the evolving MFN policy landscape and the ways legal and business leaders are evaluating its potential ripple effects across global markets. The discussion will address implications for pricing strategies, market entry and launch sequencing, and the US innovation pipeline. Analysis Group is pleased to be an associate sponsor of the event.